Sacroiliac Fusion Implants Market: Increase in the Number of Skilled Orthopedic Surgeons to Drive the Market
Wilmington, Delaware, United States, Transparency Market Research Inc. – Sacroiliac joints (SI) are joints between the sacrum and ilium bones of the pelvis. The sacrum supports the spine and ilium bone supports sacrum. The sacroiliac joint is highly dependent on its strong ligamentous structure for providing support and stability to complete human body.
Read Report Overview - https://www.transparencymarketresearch.com/sacroiliac-fusion-implants-market.html
Commonly observed conditions for which SI joint fusion is indicated include sacroiliac joint dysfunction, sacroiliac joint disruption, and degenerative sacroilitis. Sacroilitis is inflammation or dysfunction of the sacroiliac joint which could result in the unilateral low back pain.
Sacroiliac joint dysfunction can be diagnosed using provocative and non-provocative maneuvers. SI joint dysfunction can be treated with minimally invasive surgery performed in either of the two ways: immediate fixation or SI joint fusion. Sacroiliac fusion systems are intended to stabilize the sacroiliac joint and provide an environment for fusion. During immediate fixation, an implant is placed across the joints.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63636
Bone grafts can be delivered within the device to promote fusion. Sacroiliac fusion surgery is gaining popularity among physicians to treat the pain related to the sacroiliac joint. According to SI-Bone, Inc., 82% of patients were satisfied with SI joint fusion surgery. Hence, patient satisfaction and least requirement of repetition of the procedure are likely to increase demand for sacroiliac fusion systems in the next few years.
Release of the treatment guidelines by the North American Spine Society and the International Society for the Advancement of Spinal Surgery and favorable reimbursement policies for the procedure by the U.S. Medicare are expected to increase the adoption of sacroiliac fusion surgeries during the forecast period. According to recent statistics released by BIBA Medical Ltd., about 18% of lower back pain is associated with the dysfunction of the sacroiliac joint.
Sedentary lifestyles resulting in hypo-motility of the joint is the major reason for the rise in prevalence of the disease across the globe. Hence, rise in prevalence of the disease, increase in adoption of minimally invasive fusion procedure, economic growth, surge in per capita health care spending, and increase in the number of skilled orthopedic surgeons are anticipated to drive the sacroiliac fusion implants market during the forecast period.
Sacroiliac joint fusion technique is not new; however, its penetration has been limited due to extensive nature of the open fusion surgery and lack of consistent data to prove the effectiveness of the minimally invasive procedure. Moreover, lack of awareness in the developing regions and high cost of the procedure is projected to restrain the sacroiliac fusion implants market during the forecast period.
The global sacroiliac fusion implants market can be segmented based on product, surgery type, end-user, and region. In terms of product, the sacroiliac fusion implants market can be classified into triangular implants, porous implants, hollow modular screws, titanium coated implants, titanium cages, and allograft dowels.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=63636
Based on surgery type, the global sacroiliac joint fusion implants market can be bifurcated into lateral transarticular surgery and posterior surgery. In terms of end-user, the sacroiliac fusion implants market can be divided into hospitals, orthopedic clinics, ambulatory surgery centers, and others. The hospitals segment is anticipated to dominate the global sacroiliac fusion implants market, owing to high preference for hospitals due to availability of various facilities under one roof and favorable reimbursement scenario.
Based on region, the global sacroiliac fusion implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a leading market for sacroiliac fusion implants owing to the presence of large geriatric population and rise in prevalence of SI joint dysfunction. High health care spending, rise in the number of minimally invasive procedures performed in the region, and high adoption of advanced technologies by the population are expected to boost sacroiliac fusion implants market growth in North America. Europe and Asia Pacific are likely to experience increased market traction due to rise in the number cases of SI joint disability and pain.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=63636
Additionally, surge in adoption of SI joint fusion surgery among surgeons, economic empowerment of emerging regions such as Asia Pacific, Latin America, and Middle East & Africa leading to an increase in affordability for minimally invasive surgery procedure, and rise in the number of sports-related injuries are anticipated to contribute to the growth of the market in emerging regions.
Key players operating in the global total sacroiliac fusion implants market include RTI Surgical, Inc., Medtronic, SI-BONE, Inc., Camber Spine, Zimmer Biomet, and Xtant Medical. These players focus on expanding product portfolios through mergers and acquisitions. For instance, in January 2018, RTI Surgical, Inc. signed an agreement to acquire Zyga Technology, Inc., a leading medical device company which has developed SImmetry Sacroiliac Joint Fusion System.
More Trending Reports by Transparency Market Research –
Intramedullary Nails Market: Increase in incidence of injuries/sports injuries and rise in prevalence of degenerative bone diseases are projected to drive the global intramedullary nail market.
Multiplex Detection Immunoassays Market: The global multiplex detection immunoassays market is on the course to surpass US$ 3.65 Bn mark by the end of 2030.
Nucleic Acid Extraction Instruments & Reagents Market: The global nucleic acid extraction instruments & reagents market is projected to cross a value of US$ 4.9 Bn by the end of 2030.
Plasma Feed Market: The global plasma feed market is on the course to surpass the market value of ~US$ 4.1 Bn by the end of 2030.
Medical Education Market: The medical education market is predicted to progress at a modest CAGR of ~5% during the assessment period.
Stool Secretory Immunoglobulin A Market: The global stool secretory immunoglobulin A (SIgA) market is on course to reach US$ 38 Mn by the end of 2030.
Prosthetic Disc Nucleus Market: The global prosthetic disc nucleus market is on course to reach ~US$ 195 Mn by the end of 2030.
Telemedicine Market: The telemedicine market was valued at US$ 27.51 Bn in 2018 and is anticipated to expand at a CAGR of 14% from 2019 to 2027.
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453